Provided are pharmaceutical compositions that comprise bacteria strains of the genus Roseburia for treating inflammatory and autoimmune diseases. Also provided are methods of treating inflammatory and autoimmune diseases using pharmaceutical compositions that comprise bacteria strains of the genus Roseburia. Inflammatory and autoimmune diseases for treatment with the disclosed pharmaceutical compositions can include asthma.